Related Party Transactions

12 Months Ended

Dec. 31, 2015

Related Party Transactions

Related Party Transactions

12. Related Party Transactions

In September 2012, the Company entered into a sublease agreement for its leased office space in Malvern, Pennsylvania with Ceptaris Therapeutics ("Ceptaris"), a company that was acquired in September 2013. Upon the acquisition, the Company terminated the sublease agreement with Ceptaris and entered into a direct sublease agreement with NeXeption, Inc. ("NeXeption") for the leased space. A member of the Company's board of directors was an executive officer of Ceptaris and is a current executive officer of NeXeption. Total payments made during the years ended December 31, 2015, 2014 and 2013 under these sublease agreements were $124,  $66, and $68, respectively (see Note 10).

In November 2012, the Company entered into a services agreement with Ceptaris under which Ceptaris provided certain professional services, administrative support and office services to the Company. In September 2013, Ceptaris terminated the agreement in accordance with its terms. In September 2013, the Company entered into a second services agreement with Ceptaris under which Ceptaris provided certain pharmaceutical development and management services to the Company. In December 2013, Ceptaris terminated the agreement in accordance with its terms, effective February 4, 2014. Total payments made to Ceptaris in connection with these agreements during the years ended December 31, 2014 and 2013 were $10 and $166, respectively.

In February 2014, the Company entered into a services agreement with NST, LLC (“NST”) under which NST provides certain pharmaceutical development, management and other administrative services to the Company. Certain officers of the Company are also founding partners of NST. Under the same agreement, the Company also provides services to NST and is reimbursed for those services. The Company may offset any payments owed by the Company to NST against payments that are owed by NST to the Company for the provision of NST personnel, including consultants, to the Company. During the year ended December 31, 2015 and 2014, gross expenses incurred by the Company under the services agreement totaled $507and $467, respectively, and gross expenses charged to NST by the Company totaled $553 and $413, respectively. For the year ended December 31, 2015 and 2014, the Company recorded $161 and $309, respectively, of general and administrative expenses and $207 and $255, respectively, as a reduction of research and development expenses related to these transactions. During the year ended December 31, 2015 and 2014, payments made to NST by the Company totaled $74 and $131, respectively, and receipts received from NST by the Company totaled $120and $77, respectively. Related to this agreement, no amounts were due to or due from NST at December 31, 2015 or 2014.